MX366954B - Derivados de c17-heteroarilo de ácido oleanólico y métodos de uso de los mismos. - Google Patents
Derivados de c17-heteroarilo de ácido oleanólico y métodos de uso de los mismos.Info
- Publication number
- MX366954B MX366954B MX2015003078A MX2015003078A MX366954B MX 366954 B MX366954 B MX 366954B MX 2015003078 A MX2015003078 A MX 2015003078A MX 2015003078 A MX2015003078 A MX 2015003078A MX 366954 B MX366954 B MX 366954B
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- oleanolic acid
- heteroaryl derivatives
- compounds
- compositions
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 title abstract 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 title abstract 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 title abstract 2
- 229940100243 oleanolic acid Drugs 0.000 title abstract 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Lubricants (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261699199P | 2012-09-10 | 2012-09-10 | |
| PCT/US2013/059015 WO2014040056A1 (en) | 2012-09-10 | 2013-09-10 | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015003078A MX2015003078A (es) | 2015-07-14 |
| MX366954B true MX366954B (es) | 2019-07-31 |
Family
ID=49253401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015003078A MX366954B (es) | 2012-09-10 | 2013-09-10 | Derivados de c17-heteroarilo de ácido oleanólico y métodos de uso de los mismos. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20140088163A1 (enExample) |
| EP (1) | EP2892911B1 (enExample) |
| JP (1) | JP6272870B2 (enExample) |
| KR (1) | KR102237364B1 (enExample) |
| CN (1) | CN104768965B (enExample) |
| AU (1) | AU2013312102B2 (enExample) |
| BR (1) | BR112015005200B1 (enExample) |
| CA (1) | CA2882417C (enExample) |
| CY (1) | CY1119762T1 (enExample) |
| DK (1) | DK2892911T3 (enExample) |
| EA (1) | EA029069B1 (enExample) |
| ES (1) | ES2644615T3 (enExample) |
| HR (1) | HRP20171565T1 (enExample) |
| HU (1) | HUE036797T2 (enExample) |
| IL (1) | IL237638B (enExample) |
| IN (1) | IN2015DN01547A (enExample) |
| LT (1) | LT2892911T (enExample) |
| ME (1) | ME02911B (enExample) |
| MX (1) | MX366954B (enExample) |
| NZ (1) | NZ705213A (enExample) |
| PL (1) | PL2892911T3 (enExample) |
| PT (1) | PT2892911T (enExample) |
| RS (1) | RS56563B1 (enExample) |
| SG (1) | SG11201501800UA (enExample) |
| SI (1) | SI2892911T1 (enExample) |
| SM (1) | SMT201700501T1 (enExample) |
| WO (1) | WO2014040056A1 (enExample) |
| ZA (1) | ZA201501203B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI492745B (zh) | 2008-01-11 | 2015-07-21 | Reata Pharmaceuticals Inc | 合成的三萜系化合物及其使用於治療疾病之方法 |
| DK2276493T3 (da) | 2008-04-18 | 2019-01-02 | Reata Pharmaceuticals Inc | Antioxidative inflammationsmodulatorer: oleanolsyrederivater med amino- og andre modifikationer ved c-17 |
| MX2010011435A (es) | 2008-04-18 | 2011-01-25 | Reata Pharmaceuticals Inc | Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso. |
| NZ612788A (en) | 2010-12-17 | 2015-10-30 | Reata Pharmaceuticals Inc | Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| SI3444261T1 (sl) | 2012-04-27 | 2021-04-30 | Reata Pharmaceuticals, Inc. | 2,2-difluoropropionamidni derivat bardoksolon metila, njegovi farmacevtski sestavki in polimorfi za uporabo pri zdravljenju določenih stanj |
| WO2013188818A1 (en) | 2012-06-15 | 2013-12-19 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
| PL2892912T3 (pl) | 2012-09-10 | 2019-10-31 | Reata Pharmaceuticals Inc | C17-alkanodiylowe i alkenodiylowe pochodne kwasu oleanolowego i sposoby ich zastosowania |
| US9512094B2 (en) | 2012-09-10 | 2016-12-06 | Reata Pharmaceuticals, Inc. | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
| UY35534A (es) | 2013-04-24 | 2014-10-31 | Abbvie Inc | Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso |
| NZ734292A (en) | 2015-02-12 | 2022-09-30 | Reata Pharmaceuticals Inc | Imidazolyl tricyclic enones as antioxidant inflammation modulators |
| MX386256B (es) | 2015-09-23 | 2025-03-18 | Reata Pharmaceuticals Inc | Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos. |
| WO2019055119A1 (en) | 2017-09-14 | 2019-03-21 | Phoenix Biotechnology, Inc. | METHOD AND COMPOSITION FOR TREATING VIRAL INFECTION |
| MX2019005401A (es) | 2016-11-08 | 2019-08-05 | Reata Pharmaceuticals Inc | Metodos para tratar el sindrome de alport con bardoxolona metilo o analogos de la misma. |
| CN106632574B (zh) * | 2016-12-07 | 2018-05-29 | 广东天键生物科技有限公司 | 一种化合物、其制备方法及用途 |
| TWI831738B (zh) | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物 |
| MX2020002884A (es) | 2017-09-14 | 2020-10-05 | Phoenix Biotechnology Inc | Método y composición neuroprotectora mejorada para tratar afecciones neurológicas. |
| IL279348B2 (en) | 2018-06-15 | 2026-01-01 | Reata Pharmaceuticals Inc | Decahydro-2h-naphth[1,2-d]imidazole compounds for inhibition of IL-17 and ROR-gamma |
| US12060340B2 (en) | 2018-06-20 | 2024-08-13 | Reata Pharmaceuticals, Inc | Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith |
| MX2021003643A (es) * | 2018-09-28 | 2021-08-19 | Sichuan Haisco Pharmaceutical Co Ltd | Derivados de terpenoides y usos de los mismos. |
| WO2021016191A1 (en) * | 2019-07-19 | 2021-01-28 | Reata Pharmaceuticals, Inc. | C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof |
| EP4009981B1 (en) | 2020-03-31 | 2023-08-16 | Phoenix Biotechnology, Inc. | Method and compositions for treating coronavirus infection |
| RU2020130238A (ru) | 2020-03-31 | 2022-03-14 | Феникс Байотекнолоджи, Инк. | Способ и композиции для лечения коронавирусной инфекции |
| JP7214696B2 (ja) * | 2020-10-01 | 2023-01-30 | 一般財団法人 化学物質評価研究機構 | 新規ｉｎ ｖｉｔｒｏ皮膚感作性試験法 |
| EP4259155A1 (en) | 2020-12-11 | 2023-10-18 | Reata Pharmaceuticals Holdings, LLC | Synthetic triterpenoids for use in therapy |
| US20240140986A1 (en) | 2021-01-18 | 2024-05-02 | Reata Pharmaceuticals, Inc. | Synthetic ursolic acid derivatives and methods of use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6326507B1 (en) * | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| US6974801B2 (en) * | 2002-05-13 | 2005-12-13 | The Trustees Of Dartmounth College | Inhibitors and methods of use thereof |
| TWI492745B (zh) | 2008-01-11 | 2015-07-21 | Reata Pharmaceuticals Inc | 合成的三萜系化合物及其使用於治療疾病之方法 |
| EA022588B1 (ru) * | 2008-04-18 | 2016-01-29 | Ритэ Фамэсутикл, Инк. | Антиоксидантные модуляторы воспаления: производные олеанолевой кислоты с насыщением в с-кольце |
| TW201004627A (en) | 2008-04-18 | 2010-02-01 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| WO2009129548A1 (en) * | 2008-04-18 | 2009-10-22 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives |
| DK2276493T3 (da) | 2008-04-18 | 2019-01-02 | Reata Pharmaceuticals Inc | Antioxidative inflammationsmodulatorer: oleanolsyrederivater med amino- og andre modifikationer ved c-17 |
| EP2683731B1 (en) * | 2011-03-11 | 2019-04-24 | Reata Pharmaceuticals, Inc. | C4-monomethyl triterpenoid derivatives and methods of use thereof |
| WO2013188818A1 (en) * | 2012-06-15 | 2013-12-19 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
-
2013
- 2013-09-10 CA CA2882417A patent/CA2882417C/en active Active
- 2013-09-10 HR HRP20171565TT patent/HRP20171565T1/hr unknown
- 2013-09-10 SG SG11201501800UA patent/SG11201501800UA/en unknown
- 2013-09-10 PL PL13767175T patent/PL2892911T3/pl unknown
- 2013-09-10 IN IN1547DEN2015 patent/IN2015DN01547A/en unknown
- 2013-09-10 JP JP2015531317A patent/JP6272870B2/ja active Active
- 2013-09-10 WO PCT/US2013/059015 patent/WO2014040056A1/en not_active Ceased
- 2013-09-10 BR BR112015005200-2A patent/BR112015005200B1/pt active IP Right Grant
- 2013-09-10 HU HUE13767175A patent/HUE036797T2/hu unknown
- 2013-09-10 KR KR1020157009160A patent/KR102237364B1/ko active Active
- 2013-09-10 SM SM20170501T patent/SMT201700501T1/it unknown
- 2013-09-10 ME MEP-2017-254A patent/ME02911B/me unknown
- 2013-09-10 SI SI201330818T patent/SI2892911T1/sl unknown
- 2013-09-10 EP EP13767175.6A patent/EP2892911B1/en active Active
- 2013-09-10 MX MX2015003078A patent/MX366954B/es active IP Right Grant
- 2013-09-10 ES ES13767175.6T patent/ES2644615T3/es active Active
- 2013-09-10 DK DK13767175.6T patent/DK2892911T3/en active
- 2013-09-10 EA EA201590539A patent/EA029069B1/ru unknown
- 2013-09-10 US US14/022,843 patent/US20140088163A1/en not_active Abandoned
- 2013-09-10 CN CN201380057684.2A patent/CN104768965B/zh active Active
- 2013-09-10 AU AU2013312102A patent/AU2013312102B2/en active Active
- 2013-09-10 RS RS20171140A patent/RS56563B1/sr unknown
- 2013-09-10 LT LTEP13767175.6T patent/LT2892911T/lt unknown
- 2013-09-10 NZ NZ705213A patent/NZ705213A/en unknown
- 2013-09-10 PT PT137671756T patent/PT2892911T/pt unknown
-
2015
- 2015-02-23 ZA ZA2015/01203A patent/ZA201501203B/en unknown
- 2015-03-09 IL IL237638A patent/IL237638B/en active IP Right Grant
-
2017
- 2017-11-03 CY CY20171101157T patent/CY1119762T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ705213A (en) | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof | |
| PH12015500491A1 (en) | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof | |
| MX348862B (es) | Derivados c4-monometil triterpenoides y sus metodos de uso. | |
| WO2012083306A3 (en) | Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators | |
| WO2009129545A8 (en) | Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring | |
| MX2011008864A (es) | Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales. | |
| PH12016501192A1 (en) | Tetrahydropyridopyrazines modulators of gpr6 | |
| PT2470546E (pt) | Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor | |
| PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
| PH12015501609A1 (en) | Phenicol antibacterials | |
| BR112012029647A2 (pt) | novos derivados de pirimidinas | |
| MX364069B (es) | Moduladores de la proteína activadora de 5-lipoxigenasa. | |
| GEP20207108B (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| AU2014230812A8 (en) | Process for making benzoxazepin compounds | |
| IN2015DN00950A (enExample) | ||
| MX355303B (es) | Compuestos novedosos. | |
| MX2013006670A (es) | Derivado de 2-carboxamida-4-piperazinil-benzofurano. | |
| NZ705902A (en) | Isoxazolidine derivatives | |
| MX2013009386A (es) | Nuevos compuestos de azaespirodecanona. | |
| GEP20156247B (en) | Novel dihydrobenzoxathiazepine derivatives, preparation thereof, and pharmaceutical compositions containing them | |
| MX2016005222A (es) | Tinturas acidas, proceso para su produccion y su uso. | |
| TN2011000518A1 (en) | Fused imidazole carboxamides as trpv3 modulators | |
| HK1220688A1 (zh) | 有機化合物 | |
| TN2011000020A1 (en) | cMET INHIBITORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |